Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients

African Health Sciences

Volumn 7, Issue 2, 2007, Pages 86-92

  Byakika Kibwika, Pauline ^a   Ddumba, Edward ^a   Kamya, Moses ^a  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

Author keywords

Antimalarial treatment response; HIV; Malaria; Uganda

Indexed keywords

CHLOROQUINE; COTRIMOXAZOLE; FANSIDAR; PARACETAMOL; QUININE;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FEVER; FOLLOW UP; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; SINGLE DRUG DOSE; UGANDA;

CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALARIA, FALCIPARUM; MALE; OUTCOME ASSESSMENT (HEALTH CARE); TREATMENT FAILURE; UGANDA;

EID: 34547822932     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. WHO. Malaria. Wkly Epidemiol Rev 1982-1997;74:265-272.
2. French N, Nakiyingi J, Lugada E, et al., Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. Aids 2001; 15(7):899-906
3. Francesconi P, Fabiani M, Dente MG, et al., HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. Aids 2001;15(18):2445-50.
4. Whitworth J, Morgan D, Quigley M, et al., Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356(9235):1051-6.
5. Kamya MR, Gasasira AF, Yeka A, et al., Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 2006; 193(1):9-15.
6. Kamya MR, Kigonya CN, McFarland W. HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children. Aids 2001; 15(9):1187-8.
7. Colebunders R, Bahwe Y, Nekwei W, et al., Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. J Infect 1990; 21(2):167-73.
8. Greenberg AE, Nsa W, Ryder RW, et al., Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. N Engl J Med 1991; 325(2):105-9.
9. Nguyen-Dinh P, Greenberg AE, Mann JM, et al., Absence of association between Plasmodium falciparum malaria and human immunodefidency virus infection in children in Kinshasa, Zaire. Bull World Health Organ 1987; 65(5):607-13.
10. Birku Y, Mekonnen E, Bjorkman A, et al., Delayed parasite clearance of plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Ethiop Med J. 2002;40(1):17-26.
11. Chandramohan D GB. Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? Int J Epidemiol 1998; 27:296-301.
12. Simooya OO, Mwendapole RM, Sikateyo BM. Severe falciparum malaria and the acquired immunodeficiency syndrome (AIDS) in Zambia. Ann Trop Med Parasitol 1991; 85(2):269-70.
13. Jean-Pierre Van geerturuyden., Modest Mulenga., Lawrence Mwananyanda., et aal., HIV-1 Immune suppression and antimalarial Treatment Outcome in Zambian Adults with Uncomplicated Malaria. Journal of Infectious Diseases 2006; 194:917-25.
14. Kamya MR, Gasasira AF, Adoke Yeka et al., The effect of HIV on malaria treatment outcome among adults and children with uncomplicated falciparum malaria in Uganda. In; 2005.
15. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Tropica 1994;56:143-156.
16. Wernsdorfer W. Epidemiology of drug resistance in malaria. Acta Tropica 1994;56:143-156.
17. Rogier. Natural history of Plasmodium falciparum malaria and determinig factors of acquisition of antimalaria immunity in two endemic areas, Dielmo and Ndiop (Senegal). Bull Mem Acad R Med Belg 2000; 155:218-26.
18. Targett. Malaria: drug use and immune response. Parasitology 1992;105:561-70.
19. Bloland PB, Boriga DA, Ruebush TK, et al., Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. American Journal of Tropical Medicine and Hygiene 1999;60(4):641-8.
20. Rogier C, Tall A, Diagne N, et al., Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal. Parassitologia 1999;41(1-3):255-59.
21. Migot F, Ouedraogo JB, Diallo J, et al., Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso. Parasite Immunol 1996; 18(7):333-9.
22. van Eijk AM, Ayisi JG, ter Kuile FO, et al., HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. Aids 2003; 17(4):595-603.
23. Grant Dorsey, Moses R Kamya, Grace Ndeezi, et al., Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 2000; 62(6):686-692.
24. Target G. Malaria: drug use and the immune response. Parasitology 1992; 105(S):61-S70.
25. Baird JK, Jones TR, Danudirgo EW., et al., Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am J Trop Med Hyg 1991;45:65-76.
26. Grimwade KS, G. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV Cochrane library 2004(2).
27. Thera MA, Sehdev PS, Coulibaly D., et al., Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. Journal of Infectious Diseases 205; 192:1823-1829.
28. Whitty CJ, Jaffar S, Plasmodium falciparum cross-resistance. Lancet 2002; 359(80).
29. Feikin DR, Dowell S, Nwanyanwu O. Increased carriage of trimethoprim/ sulfamethoxazole-resistant S. pneumoniae in Malawian children after treatment for malaria with sufadoxine/pyrimethamine. J Infect Dis 2000; 181:1501-5.
30. Iyer JK, Milhous W, Cortese JR, et al., P.falciparum cross resistance between trimethoprim and pyrimethamine. Lancet 2000; 358:1006-67.
31. Mermin J, Lule J, Ekwaru JP, et al., Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. Aids 2005; 19(10):1035-42.